Check back here regularly for new funding opportunities. Please get in touch with us to discuss potential collaborations.
NIHR Efficacy and Mechanism Evaluation Programme: Mitigation of the adverse effects of health and social care interventions
Stage 1 applications are invited for this call on the ‘Mitigation of the adverse effects of health and social care interventions’.
Areas of interest include, but are not limited to:
- Novel interventions to reduce adverse effects (e.g. to stop misprescribing)
- Novel interventions to identify patients at increased risk of adverse effects
- Studies to stratify patients to an established treatment that has very severe adverse effects
- Development of health technologies which promise an improved safety profile.
- Additive interventions which may improve the safety profile of existing technologies
- Pharmacogenomic strategies to mitigate the risks of exaggerated or diminished drug responses.
Deadline: 1pm on 16th April 2020
The EME programme will run a webinar to support applications for this call on Tuesday 21st January, 12-1pm.
This funding call relates to the NCRI LWBC James Lind Alliance Priority #6: “How can the short-term, long-term and late effects of cancer treatments be a) prevented and/or b) best treated/managed?
Cancer Research UK: Children and Young People’s Cancer Innovation Award
The Children and Young People’s Cancer Innovation Award is a new initiative to support novel and innovative approaches to childhood cancer research.
Amount: £1m, up to 3 years
Closing date: Friday 10th January 2020
PHIND: Systems based approaches to Public Health intervention development
This call seeks to:
- Encourage the development of innovative, novel and scalable interventions which address an important UK or global public health issue
- Support the development of population-level interventions
“Population” is defined as a group of individuals an intervention may take place within, for example, schools, prisons, or larger communities and regions
Examples of the focus of population-level interventions include transport, education, employment, leisure and the built environment
Closing date: 22 Jan 2020 16:00 GMT
Tackling multimorbidity at scale: Understanding disease clusters, determinants & biological pathways
Amount: Consolidator grant up to £100k; Research Collaborative award up to £5m
Deadline: 11 February 2020
- Identify and describe new disease clusters
- Multimorbidity at different stages of the life course
- Uncovering, validating and targeting shared determinants and mechanistic pathways
- Early detection/prediction